Intrafetal Digoxin as an Adjuvant for Dilation and Evacuation at 20 to 24 Weeks' Gestation
Status:
Completed
Trial end date:
2018-05-31
Target enrollment:
Participant gender:
Summary
This is a research study to measure the effect of digoxin injection on Dilation and
Evacuation (D&E) procedure duration. Digoxin is the most commonly used feticidal agent among
family planning subspecialists, and is commonly used for a variety of reasons including
provider preference, patient preference, and concerns over legal status of later D&E
procedures. There have been several studies on digoxin administration, adverse effects, and
impact on the D&E procedure, but doctors want to clarify how digoxin effects D&E procedure
time, if at all.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
FPA Women's Health FPA Women’s Health Oregon Health and Science University Society of Family Planning